Next Article in Journal
Flexible and Versatile as a Chameleon—Sophisticated Functions of microRNA-199a
Next Article in Special Issue
Monocyte Chemotactic Protein-1 as a Potential Biomarker for Early Anti-Thrombotic Therapy after Ischemic Stroke
Previous Article in Journal
Function and 3D Structure of the N-Glycans on Glycoproteins
Previous Article in Special Issue
Clinical Neuroprotective Drugs for Treatment and Prevention of Stroke
Article Menu

Export Article

Open AccessReview
Int. J. Mol. Sci. 2012, 13(7), 8430-8448;

Effect of PACAP in Central and Peripheral Nerve Injuries

PTE-MTA “Lendulet” PACAP Research Team, Department of Anatomy, University of Pecs, Szigeti. u. 12, H-7624 Pecs, Hungary
MTA-PTE Clinical Neuroscience MR Research Group, Department of Neurosurgery, University of Pecs, Ret u. 2, H-7623 Pecs, Hungary
Department of Anatomy and Neurobiology, Virginia Commonwealth University, 1101 E. Marshall Street Richmond, Richmond, VA 23219, USA
Department of Surgery, Medical School, University of Pecs, Ret u. 2., H-7623 Pecs, Hungary
These authors contributed equally to the present work.
Author to whom correspondence should be addressed.
Received: 11 May 2012 / Revised: 25 June 2012 / Accepted: 26 June 2012 / Published: 6 July 2012
(This article belongs to the Special Issue Neuroprotective Strategies 2012)
Full-Text   |   PDF [145 KB, uploaded 19 June 2014]


Pituitary adenylate cyclase activating polypeptide (PACAP) is a bioactive peptide with diverse effects in the nervous system. In addition to its more classic role as a neuromodulator, PACAP functions as a neurotrophic factor. Several neurotrophic factors have been shown to play an important role in the endogenous response following both cerebral ischemia and traumatic brain injury and to be effective when given exogenously. A number of studies have shown the neuroprotective effect of PACAP in different models of ischemia, neurodegenerative diseases and retinal degeneration. The aim of this review is to summarize the findings on the neuroprotective potential of PACAP in models of different traumatic nerve injuries. Expression of endogenous PACAP and its specific PAC1 receptor is elevated in different parts of the central and peripheral nervous system after traumatic injuries. Some experiments demonstrate the protective effect of exogenous PACAP treatment in different traumatic brain injury models, in facial nerve and optic nerve trauma. The upregulation of endogenous PACAP and its receptors and the protective effect of exogenous PACAP after different central and peripheral nerve injuries show the important function of PACAP in neuronal regeneration indicating that PACAP may also be a promising therapeutic agent in injuries of the nervous system. View Full-Text
Keywords: endogenous; injury; neuroprotection; pituitary adenylate cyclase activating polypeptide; trauma endogenous; injury; neuroprotection; pituitary adenylate cyclase activating polypeptide; trauma
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Tamas, A.; Reglodi, D.; Farkas, O.; Kovesdi, E.; Pal, J.; Povlishock, J.T.; Schwarcz, A.; Czeiter, E.; Szanto, Z.; Doczi, T.; Buki, A.; Bukovics, P. Effect of PACAP in Central and Peripheral Nerve Injuries. Int. J. Mol. Sci. 2012, 13, 8430-8448.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top